FDAnews Drug Daily Bulletin
Oct. 26, 2012 | Vol. 9 No. 211
EU, Israel Could Ease Trade Barriers
The International Trade Committee last month narrowly endorsed a mutual recognition deal that would allow EU-certified medicines to be exported to Israel and vice-versa without requiring additional certification for the importing country. The agreement on conformity assessment and acceptance (ACAA) would remove barriers to trade, cut manufacturers’ costs and enable products to hit the market faster. But it won’t apply for advanced therapy products, blood products or other special drug products based on human tissues and cells.
International Pharmaceutical Regulatory Monitor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.